Brain Cancer Clinical Trials

Clinical Trial: Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors

Clinical Trial: Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Clinical Trial: High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors

Clinical Trial: Yoga Therapy in Treating Patients With Malignant Brain Tumors

Clinical Trial: BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor (CONDR)

Clinical Trial: Florida Center for Brain Tumor Research (FCBTR)

Clinical Trial: Assessment of Sleep Complaints in Brain Tumor Survivors

Clinical Trial: Gliogene: Brain Tumor Linkage Study

Clinical Trial: Study of the Health Information Needs of Brain Cancer Patients

Clinical Trials: A Phase I Study of PRK787/ZK 222584 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma

For a complete listing of clinical trials pertaining to Brain Cancer via ClinicalTrials.gov, click here.

Brain Cancer News

Therapeutic vaccine for brain cancer being studied

Bevacizumab delays return of ovarian cancer

New approach improves skull-base tumor surgery

Arginine may combat immunosuppression in glioblastoma

LATE-BREAKING NEWS: FDA revokes Avastin breast cancer indication

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

Cancer care is expensive.
CancerCare can help.


Connect Booklets

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey


 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions